Signals of transformation
Breakthroughs. Better outcomes. New biological possibilities.
A living intelligence feed following meaningful movement across psychedelic medicine, cannabinoid science, neuroplasticity, longevity, and regenerative biomedicine.
Research watch · July 2026
Selected developments with a direct route to the primary paper or trial record.
Retrieving the latest reviewed public intelligence.
Clear the active filters or explore another intelligence channel.
The curated newsroom remains available. Try the live intelligence view again shortly.
Featured signal Human study · exploratory
A placebo-controlled multimodal study of 28 psychedelic-naive participants detected anatomical and functional changes after 25 mg psilocybin. Acute brain entropy predicted later psychological insight and well-being.
Open primary paper in a new tabClinical result Phase 3
In an 820-person randomized trial, the chemically defined extract produced a statistically greater reduction in pain than placebo and improved neuropathic symptoms, sleep quality, and physical function.
Open primary paper in a new tabMechanism Preclinical
Cell-type-specific imaging linked psilocybin-induced structural plasticity to 5-HT2A receptors and identified the pyramidal neurons required for its long-term stress-related behavioural effects.
Open primary paper in a new tabTrial watch Registered
A placebo-controlled study is investigating whether psilocybin changes synaptic vesicle density—and whether any change is associated with cognitive improvement—in amnestic mild cognitive impairment.
Open trial record in a new tabEvidence compass
Clinical and observational Signals foreground participants, endpoints, study design, and reported outcome movement.
Mechanistic Signals track cellular, neural, metabolic, and regenerative findings while keeping preclinical evidence clearly identified.
Registered-trial Signals follows active questions, study status, and the primary registry record before results exist.
The TR4NSFORM lens
Signals prioritises discoveries, outcome movement, new mechanisms, clinical progress, and the research changing how health can be approached. Deeper intelligence connects these developments to the gateway’s protocol library.